Page last updated: 2024-10-25

clioquinol and Hematologic Malignancies

clioquinol has been researched along with Hematologic Malignancies in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Research Excerpts

ExcerptRelevanceReference
"Clioquinol is a small-molecule metal ionophore that inhibits the enzymatic activity of the proteasome and displays preclinical efficacy in hematologic malignancies in vitro and in vivo."9.16A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies. ( Ackloo, S; Booth, T; Brandwein, J; Chen, C; Chen, J; Gronda, M; Gupta, V; Jitkova, Y; Keays, S; Minden, MD; Schimmer, AD; Schuh, A; Wang, Z; Yee, K, 2012)
"Clioquinol is a small-molecule metal ionophore that inhibits the enzymatic activity of the proteasome and displays preclinical efficacy in hematologic malignancies in vitro and in vivo."5.16A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies. ( Ackloo, S; Booth, T; Brandwein, J; Chen, C; Chen, J; Gronda, M; Gupta, V; Jitkova, Y; Keays, S; Minden, MD; Schimmer, AD; Schuh, A; Wang, Z; Yee, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schimmer, AD1
Jitkova, Y1
Gronda, M1
Wang, Z1
Brandwein, J1
Chen, C1
Gupta, V1
Schuh, A1
Yee, K1
Chen, J1
Ackloo, S1
Booth, T1
Keays, S1
Minden, MD1

Trials

1 trial available for clioquinol and Hematologic Malignancies

ArticleYear
A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies.
    Clinical lymphoma, myeloma & leukemia, 2012, Volume: 12, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Clioquinol; Drug Administration Schedule; Female; Follow-Up Studies;

2012